# Cerus Corp: filings

CERS · Nasdaq · CIK 1020214 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cers.md) · [Financials](/companies/cers/financials.md) · [Filings](/companies/cers/filings.md) · [Insiders](/companies/cers/insiders.md)

## Reports and events: 276 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 528, 8-K 183, SC 13G/A 68, CT ORDER 56, 10-Q 53, DEFA14A 22, 144 20, 424B5 20, 10-K 18, DEF 14A 18, 3 14, 4/A 14, S-8 14, SD 13, UPLOAD 13, CORRESP 12, SC 13G 12, ARS 10, SCHEDULE 13G/A 9, EFFECT 5, 3/A 4, S-3 4, S-3/A 4, PRE 14A 3, 10-Q/A 2, SEC STAFF LETTER 2, 10-K/A 1, 15-12G 1, 8-A12G 1, 8-A12G/A 1, 8-K/A 1, DEFR14A 1, POS AM 1, POSASR 1, S-3ASR 1, S-3MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 16:44 ET | [10-Q](/filings/0001193125-26-326295.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326295 |
| 2026-07-30 | 16:03 ET | [8-K](/filings/0001193125-26-326093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326093 |
| 2026-07-10 | 16:35 ET | [8-K](/filings/0001020214-26-000015.md) | 5.02 Departure or appointment of officers or directors | 0001020214-26-000015 |
| 2026-06-08 | 16:20 ET | [8-K](/filings/0001193125-26-261794.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-26-261794 |
| 2026-06-03 | 16:17 ET | [8-K](/filings/0001193125-26-255488.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-255488 |
| 2026-04-30 | 17:05 ET | [10-Q](/filings/0001193125-26-197777.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197777 |
| 2026-04-30 | 16:02 ET | [8-K](/filings/0001193125-26-197129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-197129 |
| 2026-04-22 | 12:00 ET | [DEF 14A](/filings/0001020214-26-000011.md) | Proxy statement, period 2026-04-22 | 0001020214-26-000011 |
| 2026-04-21 | 16:21 ET | [8-K](/filings/0001020214-26-000007.md) | 5.02 Departure or appointment of officers or directors | 0001020214-26-000007 |
| 2026-03-16 | 17:18 ET | [8-K](/filings/0001193125-26-108629.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-108629 |
| 2026-03-02 | 17:03 ET | [10-K](/filings/0001193125-26-085678.md) | Annual report, period 2025-12-31 | 0001193125-26-085678 |
| 2026-03-02 | 16:03 ET | [8-K](/filings/0001193125-26-085350.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-085350 |
| 2026-01-23 | 16:24 ET | [8-K](/filings/0001193125-26-021085.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-021085 |
| 2026-01-12 | 08:06 ET | [8-K](/filings/0001193125-26-009824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009824 |
| 2025-11-06 | 17:01 ET | [10-Q](/filings/0001193125-25-270039.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270039 |
| 2025-11-06 | 16:03 ET | [8-K](/filings/0001193125-25-269451.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269451 |
| 2025-08-05 | 16:52 ET | [10-Q](/filings/0000950170-25-103179.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103179 |
| 2025-08-05 | 16:02 ET | [8-K](/filings/0000950170-25-102976.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102976 |
| 2025-06-23 | 16:32 ET | [8-K](/filings/0000950170-25-089029.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-089029 |
| 2025-06-09 | 13:39 ET | [8-K](/filings/0000950170-25-083561.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-083561 |
| 2025-05-01 | 17:06 ET | [10-Q](/filings/0000950170-25-061995.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061995 |
| 2025-05-01 | 16:03 ET | [8-K](/filings/0000950170-25-061808.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061808 |
| 2025-04-23 | 12:33 ET | [DEF 14A](/filings/0000950170-25-057130.md) | Proxy statement, period 2025-04-23 | 0000950170-25-057130 |
| 2025-02-26 | 17:03 ET | [10-K](/filings/0000950170-25-027906.md) | Annual report, period 2024-12-31 | 0000950170-25-027906 |
| 2025-02-20 | 16:01 ET | [8-K](/filings/0000950170-25-024125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-024125 |
| 2025-02-06 | 16:02 ET | [8-K](/filings/0000950170-25-015365.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-015365 |
| 2025-01-13 | 08:32 ET | [8-K](/filings/0000950170-25-004588.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-004588 |
| 2024-12-09 | 16:59 ET | [8-K](/filings/0000950170-24-134618.md) | 1.01 Entry into a material agreement | 0000950170-24-134618 |
| 2024-10-31 | 16:11 ET | [10-Q](/filings/0000950170-24-119535.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119535 |
| 2024-10-30 | 16:01 ET | [8-K](/filings/0000950170-24-118948.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118948 |
| 2024-10-16 | 16:59 ET | [8-K](/filings/0001193125-24-238169.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-238169 |
| 2024-08-01 | 16:54 ET | [10-Q](/filings/0000950170-24-089390.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089390 |
| 2024-08-01 | 16:02 ET | [8-K](/filings/0000950170-24-089234.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089234 |
| 2024-07-02 | 16:02 ET | [8-K](/filings/0000950170-24-080426.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-080426 |
| 2024-06-11 | 16:03 ET | [8-K](/filings/0000950170-24-071855.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-071855 |
| 2024-05-02 | 17:02 ET | [10-Q](/filings/0000950170-24-052296.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052296 |
| 2024-05-02 | 16:02 ET | [8-K](/filings/0000950170-24-052053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052053 |
| 2024-04-26 | 12:00 ET | [DEF 14A](/filings/0000950170-24-048801.md) | Proxy statement, period 2024-04-25 | 0000950170-24-048801 |
| 2024-03-19 | 08:02 ET | [8-K](/filings/0000950170-24-033155.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-033155 |
| 2024-03-05 | 16:58 ET | [10-K](/filings/0000950170-24-026195.md) | Annual report, period 2023-12-31 | 0000950170-24-026195 |
| 2024-03-05 | 16:08 ET | [8-K](/filings/0000950170-24-025891.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-025891 |
| 2024-01-08 | 08:32 ET | [8-K](/filings/0000950170-24-002726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-002726 |
| 2024-01-05 | 16:05 ET | [8-K](/filings/0001193125-24-003356.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003356 |
| 2023-11-02 | 16:53 ET | [10-Q](/filings/0000950170-23-058320.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058320 |
| 2023-11-02 | 16:02 ET | [8-K](/filings/0000950170-23-058154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-058154 |
| 2023-08-03 | 16:24 ET | [10-Q](/filings/0000950170-23-038056.md) | Quarterly report, period 2023-06-30 | 0000950170-23-038056 |
| 2023-08-02 | 16:02 ET | [8-K](/filings/0000950170-23-037123.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037123 |
| 2023-06-12 | 09:39 ET | [8-K](/filings/0000950170-23-027377.md) | 5.07 Shareholder vote results | 0000950170-23-027377 |
| 2023-05-04 | 17:09 ET | [10-Q](/filings/0000950170-23-017965.md) | Quarterly report, period 2023-03-31 | 0000950170-23-017965 |
| 2023-05-04 | 16:13 ET | [8-K](/filings/0000950170-23-017869.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017869 |

Page 1 of 6. [Older](/companies/cers/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.